Skip to main content

Table 2 Functional and biochemical markers of performance and recovery in absolute values. Values are expressed as mean, standard deviations (± SDs) and confidence intervals

From: Does photobiomodulation therapy combined to static magnetic field (PBMT-sMF) promote ergogenic effects even when the exercised muscle group is not irradiated? A randomized, triple-blind, placebo-controlled trial

Variable Group Baseline Immediately after 1 h 24 h 48 h 72 h
MVC
(Nm)
Placebo 228.28 (± 30.27) 177.21 (± 27.33) 172.98 (± 29.38) 171.21 (± 29.40) 167.65 (± 29.80) 193.15 (± 29.95)
[209.52–247.04] [160.27–194.14] [154.77–191.19] [152.99–189.43] [149.18–186.12] [174.59–211.71]
Local 231.72 (± 34.74) 213.54 (± 32.58)b 203.03 (± 30.23)b 213,74 (± 32.48)a,b 225.30 (± 29.45)a,b 249.59 (± 37.58)a,b
[210.19–253.25] [193.35–233.73] [184.29–221.77] [193.61–233.87] [207.05–243.55] [226.30–272.88]
Non-local 213.11 (± 30.04) 171.93 (± 29.88) 155.63 (± 25.18) 164.56 (± 21.51) 181.08 (± 30.32) 178.74 (± 21.74)
[194.49–231.73] [153.41–190.45] [140.02–171.24] [151.23–177.89] [162.29–199.87] [165.27–192.21]
CK
(U.L−1)
Placebo 43.87 (± 16.28) 43.31 (± 15.16) 58.51 (± 20.73) 162.31 (± 56.01) 234.97 (± 87.49) 233.60 (± 94.19)
[33.78–53.96] [33.91–52.71] [45.66–71.36] [127.60–197.02] [180.74–289.20] [175.22–291.98]
Local 38.20 (± 11.29) 34.70 (± 12.83) 35.38 (± 15.34) 69.83 (± 30.35) a,b 74.80 (± 35.68)a,b 54.53 (± 28.85) a,b
[31.20–45.20] [26.75–42.65] [25.87–44.89] [51.02–88.64] [52.69–96.91] [36.65–72.41]
Non-local 50.49 (± 12.89) 49.74 (± 15.09) 59.62 (± 16.02) 168.98 (± 61.69) 252.83 (± 118.01) 296.81 (± 88.28)
[42.50–58.48] [40.39–59.09] [49.69–69.55] [130.74–207.22] [179.69–325.97] [242.09–351.53]
DOMS
(VAS - mm)
Placebo 0 (± 0) 13.10 (± 7.56) 37.40 (± 17.42) 49.70 (± 14.25) 52.30 (± 20.12) 50.60 (± 20.38)
[0–0] [8.40–17.80] [26.60–48.20] [40.80–58.60] [39.80–64.80] [38.00–63.20]
Local 0 (± 0) 21.40 (± 14.17) 12.30 (± 14.28) a,b 16.60 (± 15.59) a,b 23.20 (± 17.83) a,b 20.40 (± 15.49) a,b
[0–0] [12.60–30.30] [3.40–21.20] [6.90–26.30] [12.20–34.20] [10.80–30.00]
Non-local 0 (± 0) 21.70 (± 11.45) 42.40 (± 25.65) 54.50 (± 30.70) 65.90 (± 27.98) 57.20 (± 31.14)
[0–0] [14.60–28.80] [26.50–58.30] [35.50–73.50] [48.50–83.30] [37.90–76.50]
Lactate
(mmol. L− 1)
Placebo 2.45 (± 0.83) 4.73 (± 1.47) 2.30 (± 0.84)    
[1.94–2.96] [3.82–5.64] [1.78–2.82]
Local 2.56 (± 0.44) 3.35 (± 0.76) a,b 2.14 (± 0.33)    
[2.29–2.83] [2.88–3.82] [1.94–2.34]
Non-local 2.06 (± 0.52) 4.62 (± 1.67) 2.31 (± 0.60)    
[1.74–2.38] [3.58–5.66] [1.94–2.68]
  1. aDifferent compared to Placebo group (p < 0.05)
  2. bDifferent compared to Non-local group (p < 0.05)